Literature DB >> 15902565

Clinical response to sildenafil in pulmonary hypertension associated with Gaucher disease.

C J C Fernandes1, C Jardim, L A S Carvalho, A Q Farias, M Terra Filho, R Souza.   

Abstract

There are few reports of pulmonary hypertension in Gaucher disease. We report a patient who showed significant clinical improvement after treatment with sildenafil.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15902565     DOI： 10.1007/s10545-005-0603-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


  4 in total

Review 1.  Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?

Authors:  Jason Weatherald; Laurent Savale; Marc Humbert
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

2.  Macitentan in the treatment of pulmonary hypertension in Gaucher‚s disease.

Authors:  Gokay Taylan; Meryem Aktoz; Mehmet Celik; Mustafa Yılmaztepe
Journal:  Anatol J Cardiol       Date:  2020-01       Impact factor: 1.596

Review 3.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25

4.  Pulmonary Hypertension in General Cardiology Practice.

Authors:  Daniela Calderaro; José Leonidas Alves Junior; Caio Júlio César Dos Santos Fernandes; Rogério Souza
Journal:  Arq Bras Cardiol       Date:  2019-10-10       Impact factor: 2.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.